Variable | Emergency cancer presentation | ||
---|---|---|---|
EP (all) n | GP-EP Adjusted %a | AE-EP Adjusted %a | |
Sex | |||
Female | 262 173 | 24.0 | 61.8 |
Male | 292 448 | 23.0 | 62.9 |
Age, years | |||
25–49 | 32 311 | 19.2 | 59.6 |
50–59 | 49 447 | 21.5 | 59.6 |
60–69 | 104 695 | 23.0 | 59.8 |
70–79 | 157 853 | 24.0 | 61.8 |
≥80 | 210 315 | 24.5 | 65.5 |
Social deprivation quintiles | |||
1 least deprived | 91 724 | 25.1 | 59.6 |
2 | 108 860 | 26.2 | 59.6 |
3 | 114 391 | 25.2 | 61.2 |
4 | 118 498 | 22.7 | 64.1 |
5 most deprived | 121 148 | 19.1 | 66.6 |
Cancer type | |||
Pancreatic | 35 139 | 30.9 | 57.4 |
Ovarian | 17 286 | 28.5 | 56.7 |
AML | 12 283 | 28.9 | 54.6 |
ALL | 1251 | 31.0 | 52.7 |
Colon | 65 092 | 27.2 | 63.1 |
CUP | 45 366 | 26.3 | 63.1 |
Gallbladder | 3127 | 27.8 | 57.8 |
Sarcoma | 3781 | 26.8 | 55.2 |
Oesophageal | 14 505 | 26.3 | 62.6 |
CML | 1741 | 26.4 | 58.7 |
Small intestinal | 4746 | 25.9 | 63.1 |
Stomach | 19 000 | 24.7 | 64.5 |
NHL | 27 001 | 25.4 | 57.7 |
HL | 2015 | 26.9 | 57.0 |
Multiple myeloma | 14 349 | 24.2 | 58.3 |
Liver | 9588 | 24.6 | 62.1 |
Anal | 1230 | 24.4 | 62.7 |
Mesothelioma | 7597 | 22.3 | 59.8 |
CLL | 5694 | 21.3 | 64.8 |
Rectal | 11 161 | 22.0 | 66.6 |
Bladder | 15 989 | 20.2 | 63.0 |
Lung | 128 938 | 20.9 | 66.6 |
Kidney | 17 586 | 21.0 | 62.9 |
Prostate | 31 485 | 19.3 | 61.1 |
Intracranial endocrine | 149 | 21.6 | 51.1 |
Breast | 18 199 | 18.7 | 66.3 |
Cervical | 2565 | 19.6 | 65.6 |
Testicular | 1456 | 23.2 | 53.2 |
Uterine | 5528 | 17.4 | 61.6 |
Brain | 22 361 | 17.2 | 60.2 |
Melanoma | 2474 | 15.8 | 58.5 |
Thyroid | 1493 | 14.5 | 57.5 |
Laryngeal | 1904 | 12.3 | 68.7 |
Oropharyngeal | 1221 | 13.4 | 59.2 |
Oral | 1321 | 9.1 | 54.4 |
Year | |||
2006 | 56 104 | 31.0 | 55.3 |
2007 | 54 190 | 30.5 | 56.2 |
2008 | 55 421 | 27.9 | 59.1 |
2009 | 55 808 | 26.1 | 60.2 |
2010 | 54 450 | 23.8 | 62.1 |
2011 | 55 488 | 22.0 | 63.9 |
2012 | 56 713 | 20.2 | 65.1 |
2013 | 56 926 | 18.8 | 66.9 |
2014 | 55 379 | 18.0 | 67.1 |
2015 | 54 142 | 16.8 | 68.2 |
↵a Estimated using a multinomial logistic regression model for AE-EP, GP-EP (reference outcome), and Other-EP, fitted to all patients diagnosed through EP in 2006 to 2015 (N = 554 621), where independent variables were sex, age group, deprivation group, cancer, and year of diagnosis. Proportions were predicted where each variable’s categories, for example, female and male, were forced to have the same case mix as that of the entire sample, 2006–2015. AE-EP = emergency presentation through presentation to accident and emergency. ALL = acute lymphoblastic leukaemia. AML = acute myeloid leukaemia. CLL = chronic lymphocytic leukaemia. CML = chronic myeloid leukaemia. CUP = cancer of unknown primary. GP-EP = emergency presentation through a GP referral. EP = emergency presentation HL = Hodgkin’s lymphoma. NHL = non-Hodgkin’s lymphoma. Other-EP = emergency presentation through routes other than through the GP or accident and emergency, for example, through referral during an inpatient admission.